On Sunday 29th January 2023, celebrated photographer Bunshri Chandaria is launching Silent Voice, an artist book which depicts a photographic exploration of dementia, at an…
Read more...Alzheimer’s Research UK has welcomed new government commitments to increase healthy life expectancy and reduce ill-health in the UK, as part of its new Major…
Read more...Only 2% of the public are doing everything they can to keep their brains healthy, according to new figures released by Alzheimer’s Research UK/ Now…
Read more...– Alzheimer’s Society Ambassadors Dame Arlene Phillips and Vicky McClure will today deliver an open letter to PM Rishi Sunak calling for him to urgently…
Read more...The Food and Drug Administration has approved lecanemab, a new drug for Alzheimer’s disease, for use across the US. It’s been less than two years…
Read more...The Alzheimer’s Dementia & Care Show The Business Design Centre London 3-4 March 2023 The Carer is delighted to announce its media partnership with premier…
Read more...Hundreds more people will be checked for dementia thanks to a new specialist service being trialled across the country, the NHS has announced. Care home…
Read more...As part of its partnership with Alzheimer’s Society, The Football Association (FA) has launched permanent support schemes in County FAs, offering help and hope to anyone who…
Read more...Debbie Abrahams MP, Chair of the All-Party Parliamentary Group on Dementia, comments on the results for Alzheimer’s drug lecanemab. A paper published on Wednesday 30…
Read more...Researchers have published findings which suggest that the use of hearing aids and cochlear implants can reduce the risk of developing dementia by slowing down…
Read more...Dr Richard Oakley, Associate Director of Research at Alzheimer’s Society, comments on news surrounding breakthrough Alzheimer’s drug lecanemab. Today’s (November 30) exciting results offer our…
Read more...A new survey of carers from across the UK provides a bleak appraisal of how many of the UK’s seven million unpaid family carers have…
Read more...The Government’s recommitment to delivering the Dame Barbara Windsor Dementia Mission has been warmly welcomed by Alzheimer’s Research UK, the UK’s leading dementia research charity….
Read more...The pharmaceutical company Roche has announced that two phase III trials of the potential Alzheimer’s drug gantenerumab did not achieve the goal of slowing clinical…
Read more...Survey of nearly 2,000 people affected by dementia reveals less than half felt care staff had a good understanding of dementia and one in four…
Read more...Sign up to receive the latest issues, along with highlights of the latest sector news and more from The Carer, delivered directly to your inbox twice a week!
